Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Product Launch

23 Sep 2009 07:00

RNS Number : 4943Z
Imaginatik PLC
23 September 2009
 



23 September 2009

Imaginatik plc

("Imaginatik" or the "Company")

Launch of ChemBioConnect

CambridgeSoft and Imaginatik launch Visual Collaboration Tool for Scientists

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaboration software, announces the launch of ChemBioConnect, an online collaboration tool for use by researchers in the chemistry, biotechnology and pharmaceutical industries.

Developed in conjunction with CambridgeSoft, ChemBioConnect allows scientists to draw, view, edit, archive and search chemical structures and biological systems in a secure, robust collaboration and idea management environment. The resource effectively allows for collaborative problem-solving among scientists by combining CambridgeSoft's chemically intelligent visual toolsets with Imaginatik's research-based, enterprise-scale system, comprised of software, services and a deep understanding of how human networks operate. This offering is targeted to meet the needs of research and development professionals in the areas of pharmaceuticals, bioscience, biotechnology, chemistry and food science.

"Professional chemists think and communicate visually, whether doodling on paper, working in teams at a whiteboard, or keeping a notebook," said Dr. Robin Spencer, Senior Research Fellow at Pfizer, Inc. "At Pfizer we have seen that marrying the ability to work visually with a secure collaborative innovation environment like ChemBioConnect gives our scientists a scalable and secure new way to capture ideas and solve challenging problems."

"Collaboration is vital in all forms of business activity, and chemistry and biology are not exceptions to this rule," said Mark Turrell, CEO of Imaginatik. "ChemBioConnect is the first in a series of industry specific modules of our core collaboration software platform, Idea Central, which we intend to launch in the years ahead, supporting our growth and market leadership position." 

"We are pleased to be working together with Imaginatik," said Michael G. Tomasic, President and CEO of CambridgeSoft. "With this collaboration we are ensuring that our customers benefit from the integration of CambridgeSoft's leading chemical and biological drawing software, ChemBioDraw, with Imaginatik's innovation engine to drive collaborative problem solving for new research insights and higher efficiency."

ChemBioConnect is being sold by Imaginatik with support from CambridgeSoft.

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik is the leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the leading companies in the world use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with its highly configurable web-based software and experienced consulting team.

A World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK, Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective problem solving. The company collaborates with several academic institutions including the IXL Center at Hult International Business School. Imaginatik is publicly traded on the London Stock Exchange [AIM:IMTK.L].

For further information please visit http://www.imaginatik.com

About CambridgeSoft

CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and scientific research organizations. Software products include enterprise, workgroup and desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, with knowledge management, chemical and biological informatics, and scientific database solutions. Web sites include ChemBioFinder.Com and ChemBioNews.Com for indexed database content and news, and SciStore.Com for e-commerce. CambridgeSoft has offices in the United StatesEurope and Asia Pacific. For more information, please go to www.cambridgesoft.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUPPBUPBGQP
Date   Source Headline
30th Dec 20193:10 pmRNSHalf-year Report
2nd Dec 20197:00 amRNSFinal Results
13th Nov 20197:00 amRNSAppointment of Joint Broker
28th Oct 20193:03 pmRNSDirector Declaration
27th Sep 201911:30 amRNSUpdate, Proposed Transaction and RPT
5th Sep 20194:18 pmRNSDirectorate Change
6th Aug 20197:31 amRNSRe Suspension and Update
6th Aug 20197:30 amRNSSuspension - Abal Group Plc
2nd Aug 20199:49 amRNSUpdate on suspension date
24th Jun 20199:11 amRNSUpdate on Board Changes
3rd May 20192:01 pmRNSHolding(s) in Company
3rd May 20199:00 amRNSPrice Monitoring Extension
2nd May 201911:55 amRNSHolding(s) in Company
1st May 201911:01 amRNSHolding(s) in Company
1st May 201910:58 amRNSHolding(s) in Company
29th Apr 201910:28 amRNSHolding(s) in Company
26th Apr 201911:52 amRNSHolding(s) in Company
5th Apr 20192:22 pmRNSHolding(s) in Company
1st Apr 20198:10 amRNSUpdate on Board changes
1st Mar 20197:00 amRNSUpdate and Directorate Change
5th Feb 201911:48 amRNSHolding(s) in Company
5th Feb 201910:08 amRNSCompletion of disposal
5th Feb 20198:23 amRNSHolding(s) in Company
31st Jan 20195:30 pmRNSImaginatik
31st Jan 201910:09 amRNSHolding(s) in Company
30th Jan 20199:38 amRNSHolding(s) in Company
28th Jan 201910:27 amRNSResult of GM
14th Jan 20197:00 amRNSIssue of Equity
10th Jan 20197:00 amRNSProposed sale of business and assets
13th Dec 20183:42 pmRNSHolding(s) in Company
12th Dec 201812:37 pmRNSResult of AGM
10th Dec 20183:47 pmRNSHolding(s) in Company
4th Dec 20182:10 pmRNSHolding(s) in Company
4th Dec 20189:23 amRNSHolding(s) in Company
3rd Dec 20183:01 pmRNSIssue of Equity
3rd Dec 20187:00 amRNSContract Award
28th Nov 20183:33 pmRNSHolding(s) in Company
28th Nov 20187:00 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSResult of Open Offer
19th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSNotice of AGM
8th Nov 201812:52 pmRNSDirectorate Change
2nd Nov 20185:29 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSOpen Offer
31st Oct 201812:37 pmRNSAdmission of new shares
26th Oct 20187:30 amRNSRestoration - Imaginatik plc
26th Oct 20187:00 amRNSAppointment of NOMAD and Completion of Placing
18th Oct 20187:00 amRNSCompany Update
1st Oct 20187:00 amRNSCompany Update
28th Sep 201811:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.